CURE | TQQQ | CURE / TQQQ | |
Gain YTD | -12.980 | 7.795 | -167% |
Net Assets | 136M | 27.7B | 0% |
Total Expense Ratio | 0.93 | 0.84 | 111% |
Turnover | 23.00 | N/A | - |
Yield | 1.40 | 1.11 | 126% |
Fund Existence | 14 years | 15 years | - |
CURE | TQQQ | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago90% |
Stochastic ODDS (%) | 4 days ago90% | 4 days ago85% |
Momentum ODDS (%) | 4 days ago84% | 4 days ago90% |
MACD ODDS (%) | N/A | 4 days ago90% |
TrendWeek ODDS (%) | 4 days ago90% | 4 days ago90% |
TrendMonth ODDS (%) | 4 days ago90% | 4 days ago90% |
Advances ODDS (%) | 11 days ago90% | 4 days ago90% |
Declines ODDS (%) | 17 days ago90% | 17 days ago88% |
BollingerBands ODDS (%) | 4 days ago86% | 4 days ago89% |
Aroon ODDS (%) | 4 days ago90% | 4 days ago90% |
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with IQV. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then IQV could also see price increases.
Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
---|---|---|---|---|
CURE | 100% | N/A | ||
IQV - CURE | 65% Loosely correlated | -0.25% | ||
GEHC - CURE | 63% Loosely correlated | -0.07% | ||
TMO - CURE | 59% Loosely correlated | +0.37% | ||
MRK - CURE | 57% Loosely correlated | -1.77% | ||
JNJ - CURE | 56% Loosely correlated | +0.29% | ||
More |
A.I.dvisor indicates that over the last year, TQQQ has been closely correlated with LRCX. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if TQQQ jumps, then LRCX could also see price increases.
Ticker / NAME | Correlation To TQQQ | 1D Price Change % | ||
---|---|---|---|---|
TQQQ | 100% | +2.80% | ||
LRCX - TQQQ | 81% Closely correlated | -0.02% | ||
META - TQQQ | 78% Closely correlated | N/A | ||
ARM - TQQQ | 77% Closely correlated | +0.30% | ||
CDNS - TQQQ | 76% Closely correlated | +5.10% | ||
NXPI - TQQQ | 75% Closely correlated | +0.41% | ||
More |